{"symbol": "BLRX", "companyName": "BioLineRx Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.biolinerx.com", "description": "BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds. Its pipeline product include BL-8040, BL-9020, BL-5010, BL-1230, and AGI-134.", "CEO": "Philip Serlin", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}